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Purpose. Hypothermic machine perfusion systems seem moreeﬀective thanthe current staticstorage to prevent cold ischemic liver
injury. Thus, we test an innovative hyperbaric hypothermic machine perfusion (HHMP), which combines hyperbaric oxygenation
ofthepreservationsolutionandcontinuousperfusionofthegraft.Methods.RatliverswerepreservedwithCelsiorsolutionaccord-
ing to 4 diﬀerent modalities: normobaric static preservation; hyperbaric static preservation at 2 atmosphere absolute (ATA); normo-
baric dynamic preservation,wi t hc o n t i n u o u spe rf u s i o n ;hyperbaric dynamic preservation, with continuous perfusion at 2 ATA. After
24h cold preservation, we assessed diﬀerent parameters. Results. Compared to baseline, livers preserved with the current static
storage showed severe ultrastructural damage, glycogen depletion and an increased oxidative stress. Normobaric perfused livers
showed improved hepatocyte ultrastructure and ameliorated glycogen stores, but they still suﬀered a signiﬁcant oxidative damage.
The addition of hyperbaric oxygen produces an extra beneﬁt by improving oxidative injury and by inducing endothelial NO syn-
thase(eNOS)geneexpression.Conclusions.PreservationbymeansofthepresentinnovativeHHMPreducedtheliverinjuryoccur-
ring after the current static cold storage by lowering glycogen depletion and oxidative damage. Interestingly, only the use of hyper-
baric oxygen was associated to a blunted oxidative stress and an increased eNOS gene expression.
1.Introduction
The prevention of preservation injury is crucial to accom-
plish the early recovery of cellular metabolism after trans-
plantationandtoavoidgraftdysfunction.Tobridgethetime-
spanfromtheharvestingtotheimplantationintherecipient,
the livers are stored in preservation solutions on melting
ice at 0–4◦C, allowing a safe preservation up to 12h [1]. A
cold ischemia longer than 12h still implies a greater risk of
graft dysfunction. Furthermore, the rising demand for trans-
plantation triggers the use of the so-called extended criteria
donors, which tolerate a period of cold ischemia even shorter
than 12 hours [2].
Alteration of the energy metabolism is an important
feature of preservation injury [3]. Hypothermia at 0–4◦Ci s
a key factor for organ preservation by reducing the cellular
metabolic activity about 90–95% [4]. However, even at this
low temperature, metabolism still requires 0.27mol oxygen/
min/g of liver [4], which is not provided by the current static
storage. Oxygen is mainly taken up by mitochondria to allow
the synthesis of adenosine triphosphate (ATP); therefore,
the lack of oxygen results in failure of the respiratory chain
and ATP can solely be generated through the anaerobic
glycolysis. Once the cellular glycogen stores are consumed,
ATP depletion rapidly ensues leading to a series of events
which eventually cause irreversible cell injury and death [5].2 The Scientiﬁc World Journal
In the last decade, experimental studies have shown that
continuous perfusion of the liver during preservation can
improve graft viability and challenge the limits of the current
static storage [6–9]. However, several issues need to be clar-
iﬁed before the hypothermic machine perfusion (HMP) will
reach the clinical application, including the type of preserva-
tion solution, the characteristics of perfusion dynamics, and
the modalities of oxygen supply [4, 9]. Regarding the latter
issue, oxygenation of the solution appears to be a typical
double-edge condition: the oxygen supplied during cold
ischemia should guarantee the ATP synthesis for the residual
metabolic activity, but, at the same time, it might favor the
generation of reactive oxygen species (ROS) leading to the
exacerbation of cellular injury.
T r e a t m e n tw i t hh y p e r b a r i co x y g e ni sam e t h o dt h a te m -
ploys exposure to 100% oxygen at a pressure above 1 atmo-
sphereabsolute(1ATA)topromotetissuehyperoxygenation.
In the setting of liver diseases, hyperbaric oxygen has been
used to treat hepatic artery thrombosis after transplantation
and acute liver failure due to carbon tetrachloride intoxi-
cation [10, 11]. However, experimental data indicate that
h y p e r b a r i co x y g e ni sa l s oc a p a b l et or e d u c eh e p a t i cw a r m
ischemia-reperfusion injury by interfering with several
pathogenic mechanisms [12–14]. It has been proposed that
hyperbaric oxygen counteracts neutrophil adhesion within
the microvasculature by downregulating the expression of
endothelial cell adhesion molecules, enhance nitric oxide
(NO) production by increasing the expression of endothelial
NO synthase (eNOS), prevents lipid peroxidation, and ame-
liorates the mitochondrial oxidative phosphorylation capac-
ity [12–14]. Finally, Ijichi et al. [15] have recently showed
that hyperbaric oxygen applied to the current static storage
ameliorates preservation injury and ATP depletion in rat
livers.
Based on these observations, we aimed to determine
whetheraninnovativehyperbarichypothermicmachineper-
fusion(HHMP)thatcombinestheoxygenationofthepreser-
vation solution with hyperbaric oxygen to the continuous
perfusion of the graft improves rat liver preservation injury.
2.MaterialsandMethods
2.1. Hyperbaric Hypothermic Machine Perfusion (HHMP).
The HHMP, designed and patented by “Centro Iperbarico
s.r.l.,”Ravenna,Italy,consistsofahyperbariccontainerwhere
the organ is stored, totally immersed in the preservation
solution, with a residual free volume in the upper part con-
tainingagasmixtureof95%O2 and5%CO2.Thehyperbaric
chamberisenclosedintoaconditioningsystem,whichallows
the exact regulation and control of the temperature and
pressure (ranging form 0 to 2.5 ATA). The perfusion of the
organ with the preservation solution throughout the portal
vein is guaranteed by a peristaltic pump (Gilson Minupulse,
Villiers Le Bel, France) located outside the hyperbaric cham-
ber. A second peristaltic pump is used to generate a con-
tinuous movement of the preservation solution aiming to
enhance oxygen diﬀusion within the preservation solution.
Contrary to other HMP devices, which have been criticized
for their complicated logistics, the HHMP has been designed
to be easily carried by two persons allowing the possibility
to start the intervention immediately after procurement and
not only in the recipient’s transplant centre.
2.2. Experimental Design. Fed Sprague-Dawley rats (Char-
les-River Laboratories, Calco, Italy), weighing 250–300
grams, were anesthetized (Zoletil-100, Virbac, France) bet-
ween 9:00 and 10:00 a.m. and the abdomen opened with a
midline incision. Afterwards, heparin 500IU/liter was injec-
ted through the infrahepatic vena cava and the portal vein
cannulated with a 16G angiocath. The liver was then ﬂushed
out with20mL of coldCelsior solution, immediately explan-
tedandﬂushedoutagainwith30mLofcoldCelsiorsolution.
The livers were ﬁnally assigned to the following experimental
groups:
(1) baseline controls: liver tissue samples were immedi-
ately collected for the ultrastructural, histological,
and biochemical analysis;
(2) normobaric static preservation: livers were kept at 4◦C
in the HHMP under normobaric conditions (1 ATA)
immersed in the Celsior solution for 24h. This group
mimics the current static storage used in clinical
transplantation;
(3) hyperbaric static preservation: livers were kept at 4◦C
in the HHMP under hyperbaric conditions (2 ATA)
immersed in the Celsior solution for 24h. Compres-
sion and decompression were carried out progres-
sively at a rate of 0.2 ATA/min;
(4) normobaric dynamic preservation: livers were kept at
4◦C in the HHMP under normobaric conditions
(1ATA)andcontinuouslyperfusedwithCelsiorsolu-
tion at 1mL/min/g liver for 24h;
(5) hyperbaric dynamic preservation: livers were kept at
4◦C in the HHMP under hyperbaric conditions
(2ATA)andcontinuouslyperfusedwithCelsiorsolu-
tion at 1mL/min/g liver for 24h. Compression and
decompression were carried out progressively at a
rate of 0.2 ATA/min.
After 24h of cold preservation, tissue samples were im-
mediately collected for the ultrastructural, histological, and
biochemical analysis. This preservation time was chosen
basedonpreliminaryexperimentsshowingthatliverdamage
increased progressively as function of the duration of preser-
vation (6, 12, and 24h) and all the parameters studied be-
came signiﬁcantly diﬀerent from baseline after 24h of the
current static storage.
All procedures involving rats were conducted in accor-
dancewithinternationallyacceptedprinciplesforcareoflab-
oratory animals (EEC Council Directive 86/609, OJ L358,1,
December 12, 1987) and the guidelines approved by the eth-
ical committee of our University.
2.3. Analytical Methods
2.3.1. Liver Ultrastructure. Liver samples were cut into small
pieces, ﬁxed in 4% formaldehyde solution and postﬁxed inThe Scientiﬁc World Journal 3
1% OsO4 in 0.1M S¨ orensen buﬀer. All the samples were then
dehydrated in alcohol and embedded in Epon. Thin sections
were double-stained with uranium and lead and observed
with a Philips 410 Electron Microscope.
2.3.2. Hepatic Glycogen. PAS staining of liver tissue was per-
formed to assess the glycogen stores. Brieﬂy, the formalin-
ﬁxed and paraﬃn-embedded specimens were cut into slices
of 4μm thickness and mounted on glass slides. Thin sections
were deparaﬃnized, rehydrated in distilled water, and then
pretreated for 5min with 1% periodic acid (Fluka Chemie,
Buchs, Switzerland). After washing in mQ-water, the section
was left to react with the Schiﬀ’s reagent (Sigma-Aldrich,
Milan, Italy) for 15min at room temperature. Nuclei were
counterstainedfor2minwithMayer’shaematoxylinsolution
(Sigma-Aldrich, Milan, Italy).
2.3.3. Hepatic Oxidative Stress
GSH and GSSG Assay. Liver specimens were homogenized
in 10 volumes of 0.1mol/L potassium-phosphate buﬀer (pH
7.4) containing 5mmol/L EDTA. Enzymatic determination
of total (GSH) and oxidized (GSSG) glutathione concentra-
tions were performed by precipitating tissue homogenates
with 15% sulfosalicylic acid (SSA) [16]. The supernatant was
processed for GSH determination by the GSSG recycling
procedure and incubated with 2-vinylpiridine and trietha-
nolamine for GSSG assay [17].
PSH and PSSG Assay. Protein sulfhydryls (PSHs) were mea-
sured with a modiﬁcation of Elmann’s procedure in which
the SSA-precipitated proteins were resuspended in 700μLo f
6M guanidine, pH 6.0. Optical density was read spectropho-
tometrically at 412 and 530nm before and after 30min of
incubationwith50μLof10mM5,5-dithiobis2-nitrobenzoic
acid [18]. Protein-glutathione mixed disulﬁdes (PSSG) were
measured as previously described [19]. Proteins were precip-
itated with 15% SSA containing 0.02M EDTA and then dis-
solvedin300μLof0.2Mammoniumbicarbonatecontaining
8M urea and mixed with 5mg Na2BH4. Pentanol (50μL)
was added to avoid frothing. After 20min, proteins were
precipitated with 100μL of 15% SSA. The amount of GSH
in the supernatant obtained after centrifugation at 45,000g
for 15min was enzymatically measured [16]. Results are
expressed as nmol GSH/mg protein.
RSNO Assay. The method described by Cook et al. [20],
which uses a mixture of SULF/NEDD (sulfanilamide/N-(1-
naphtyl)ethylenediamine dihydrochloride, neutral Griess) as
reagents, was used. Liver homogenate was suspended 1:4
in PBS (pH 7.4) containing 10mM N-ethylmaleimide and
4mM potassium ferricyanide, acidiﬁed with 25% SSA, and
centrifuged at 10,000×g for 10min. The supernatant was
added to 40μL of 1% ammonium sulfamate, 200μLo f0 . 4N
HCl containing 0.3% HgCl2 and 4.6% SULF, and 300μLo f
0.4N HCl containing 0.2% NEDD. After 30min of incu-
bation at 25◦C, the samples were spectrophotometrically
analyzed at 544nm. Standards were prepared by reacting
equal molar reduced glutathione and nitrite in water. Total
protein concentration in liver homogenate did not diﬀer sig-
niﬁcantly among the experimental groups.
2.4. Endothelial and Inducible Nitric Oxide Synthase (NOS)
Gene Expression. The eNOS and iNOS gene expression was
assessed by using real-time PCR. Brieﬂy, total RNA was ex-
tracted from liver samples using Trizol/chloroform extrac-
tion (Invitrogen, Carlsbad, CA, USA). Total RNA quality was
checked on ethidium bromide-stained gel and then 1μg
reverse transcribed using SuperScript III RT (Invitrogen,
Carlsbad,CA,USA).OligonucleotideprimerspairsforeNOS
and iNOS were designed using Beacon Designer 2.0 software
(BioRad, Richmond, CA, USA) and then purchased from
Tema Ricerche s.r.l. (San Lazzaro, BO, Italy). As internal ref-
erence, primers for β-actin and β2-microglobulin were used.
Real-time quantitative PCR experiments were performed
utilizing iQSybr Green Supermix (BioRad, Richmond, CA,
USA) in the iCycler (BioRad, Richmond, CA, USA) instru-
ment. The fold changes in gene expression relative to the
levels obtained in baseline control rats, which were consi-
dered equal to 1, were analyzed and calculated with the
2−ΔΔCt method [21].
2.5. Statistical Analysis. Data were analyzed by means of the
two-way analysis of variance (ANOVA) with Bonferroni’s
post hoc test. Statistical analysis was performed by the SPSS
8.0 statistical package. Data are reported as mean values
± SE. Two-tailed P values less than 0.05 were regarded as
statistically signiﬁcant.
3. Results
3.1. Liver Ultrastructure. After 24h of the current static stor-
age, hepatocytes showed many cytoplasmatic vacuoles and
enlarged mitochondria with a reduced electron transparency
and granular electron opaque aggregates (very likely com-
posed by calcium salts) frequently found in the matrix. The
nuclei presented extensive clumping of the chromatin and
ribonucleoprotein components, while nucleoli were hardly
visualized. Sinusoidal cells were detached and their nuclei
were pycnotic (Figure 1(a)).
The ultrastructural alterations of hepatocytes and sinu-
soidal cells were clearly evident also in livers preserved
underhyperbaricstaticconditions (Figure 1(b)).Incontrast,
normobaric dynamic preservation induced a signiﬁcant
improvement of mitochondria morphology, which appeared
well preserved in most cases, even though some mitochon-
dria presented moderate swelling. However, changes in the
distribution of the nucleolar components and clumping of
the nucleoplasm ribonucleoproteins were still present. Fin-
ally, the sinusoidal cells were detached from hepatocytes
(Figure 1(c)).
Interestingly, hepatocytes of livers preserved with the
combinationofcontinuousperfusionandhyperbaricoxygen
maintained an almost regular nuclear and cytoplasmatic
ultrastructure.Nucleoli wereeasilyrecognized witha normal
distribution of the ribonucleoproteins in most cases, while
glycogen stores and mitochondrial membranes and matrix
were well preserved, showing almost no matrix swelling and4 The Scientiﬁc World Journal
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Figure 1: Transmission electron microscopy representative pictures of 24h preserved livers. (a) Normobaric static preservation; (b) hyper-
baric static preservation; (c) normobaric dynamic preservation; and (d) hyperbaric dynamic preservation.
no membrane changes. Finally, sinusoidal cells appeared to
be characterized by pycnotic nuclei (Figure 1(d)).
3.2. Hepatic Glycogen. Although the periodic acid Schiﬀ
staining allows only a qualitative evaluation, the hepatic gly-
cogen content was clearly depleted after the current static
storage (Figure 2(a)) .W h i l eh y p e r b a r i s ma l o n es e e m st o
have only a marginal eﬀect (Figure 2(b)), dynamic preser-
vation both with normobaric (Figure 2(c)) and hyperbaric
oxygen (Figure 2(d)) appears to guarantee the maintenance
of the baseline glycogen levels (Figure 2(e)).
3.3. Hepatic Oxidative Stress. T h et i s s u ec o n t e n to fG S H ,
the major antioxidant in the liver, was signiﬁcantly reduced
after the current static storage as compared to the baseline
level (Figure 3(a)). Taken into account the concomitant rise
of GSSG, the oxidized form of glutathione (Figure 3(b)),
one may conclude that the current static storage is asso-
ciated with the occurrence of a signiﬁcant oxidative stress,
as shown by the increased GSSG/GSH ratio (Figure 3(c)).
While normobaric dynamic preservation had no eﬀect on
these alterations, hyperbaric oxygen both under static and
dynamic conditions partially counterbalanced the redox
changes of the glutathione status.
The changes of PSH and PSSG mirror those of GSH and
GSSG (Figure 4).
Finally, the RSNO content, which represents an impor-
tant quote of nitric oxide (NO) bound to free thiols, was
reduced by 40% in livers preserved with the current static
storage.Again,hyperbaricoxygenbothunderstaticanddyn-
amic conditions prevented the RSNO depletion. In contrast,
noeﬀectwasseenwhencontinuousperfusionwasperformed
under normobaric condition (Figure 5).
3.4. Hepatic Gene Expression of eNOS and iNOS. The basal
preischemic gene expression of eNOS remained substantially
unchanged in the livers maintained for 24h under the cur-
rent static cold storage. While perfusion alone had no evi-
dent eﬀect, hyperbaric preservation was associated with an
increased eNOS gene expression although a statistical sig-
niﬁcant diﬀerence was reached only in the group combin-
ing continuous perfusion and hyperbaric oxygenation
(Figure 6). In contrast, the gene expression of the iNOSThe Scientiﬁc World Journal 5
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Figure 2: Representative histological pictures of the liver PAS-stained glycogen. (a) Normobaric static preservation; (b) hyperbaric static
preservation; (c) normobaric dynamic preservation; (d) hyperbaric dynamic preservation; and (e) baseline controls.
isoform after 24h preservation was similar in all the expe-
rimental groups to that observed in basal preischemic livers
(data not shown).
4. Discussion
The HMP has been shown to challenge the limits of the
current static storage in experimental liver transplantation,
by providing continuous nutrients and oxygen supply to the
organ and by removing the waste products, thus improving
parenchymal cell viability and function even after prolonged
cold ischemia [4, 9]. More recently, a pilot study has also
shown the safety and feasibility of liver preservation with
HMP in 20 liver transplanted patients [22, 23]. Although
active oxygenation of the preservation solution was not pro-
vided by the HMP used in this study, the pO2 levels in the
eﬄuent perfusate remained relatively high and stable during
preservation as a result of ambient air interchange at the
organ chamber [22].
The hyperbaric hypothermic machine perfusion
(HHMP)described in ourstudyrepresentsaninnovative ap-
proach against liver preservation injury, which combines the
oxygenation of the preservation solution with hyperbaric
oxygen to the continuous graft perfusion as performed by
the actual HMPs. We found that hyperbaric oxygen, besides
maintaining the positive eﬀects of continuous perfusion on
ultrastructural damage and glycogen depletion, produces an
extra beneﬁt by reducing the oxidative injury occurring6 The Scientiﬁc World Journal
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Figure 3:Totalglutathione(GSH)concentration(a),oxidizedglutathione(GSSG)concentration(b),andoxidized/totalglutathione(GSSG/
GSH) ratio (c) in baseline controls and 24h preserved livers according to the study protocol. Data are expressed as means ± SE.
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Figure 4: Protein sulfhydryls (PSH) concentration (a) and protein-glutathione mixed disulﬁdes (PSSG) concentration (b) in baseline con-
trols and 24h preserved livers according to the study protocol. Data are expressed as means ± SE.
during preservation under normobaric conditions and by
inducing eNOS gene expression.
In these experiments, a signiﬁcant oxidative damage
occurred after 24h of static or dynamic normobaric preser-
vation, as indicated by the increased oxidized glutathione
and the GSSG/GSH ratio and by the reduced PSH. The
enhanced production of ROS during cold ischemia has been
already reported [24, 25] and only apparently it represents
a paradox. Indeed, the decrease of O2 concentration to the
h y p o x i cr a n g eo f5t o0 . 5 %[ 26] would lower mitochondrialThe Scientiﬁc World Journal 7
respiration andenhancethereductionstateofthemitochon-
drial redox centres, favouring the electron leak to molecular
oxygen and ROS production, mainly by the respiratory com-
plexes I and III [27]. Thus, oxygen acts as a double-edged
sword during cold preservation: its supply is mandatory to
support aerobic metabolism and maintain ATP levels in the
hepatocytes, but it is also potentially harmful by increasing
the generation of toxic ROS.
In contrast, preservation with hyperbaric oxygen was
associated with decreased oxidative injury. Although previ-
ous studies have shown that hyperbaric oxygen reduce lipid
peroxidation in several prooxidant experimental models [12,
28, 29], the underlying mechanisms of protection are still
elusive. It can be hypothesized that hyperbaric oxygen fa-
vours an eﬃcient electron transfer through the OXPHPOS
complexes, as suggested by the great improvement of ultra-
structural mitochondrial damage observed in a previous
work [30], and reduces ROS formation, which eventually
may prevent the GSH oxidative consumption.
However, under static conditions, hyperbaric oxygen re-
duces oxidative damage without improving mitochondrial
damage, thus suggesting the existence of other mechanisms.
Nitrosothiols are unstable thioesters exerting diﬀerent intra-
and extracellular functions only in part deﬁned [31]. Recent
experimental evidences suggest that protein S-nitrosylation
could modulate ROS production and limit oxidative damage
during ischemia reperfusion in the heart and liver [32]. In
our experiments, liver preserved under hyperbaric condi-
tions maintain the baseline nitrosothiols levels, which are
instead signiﬁcantly reduced after normobaric preservation.
Since protein S-nitrosylation has emerged as an eﬀector of
NO bioactivity [33], it is also tempting to speculate that the
prevention of nitrosothiols depletion may be related to an
increased generation of NO from eNOS, as suggested by the
induction of its gene expression in livers preserved under
hyperbaric conditions.
Beside the eﬀect on protein S-nitrosylation and oxidative
stress,agreateravailabilityinthevascularbedofeNOSgene-
rated NO may have other potential beneﬁts by favouring
vasodilatation and capillary ﬂow and by reducing neutrophil
adherence during reperfusion of the graft [13–15]. As we
were not able to observe any signiﬁcant eﬀect on iNOS gene
expression, our results support the ﬁnding of previous stu-
dies that hyperbaric oxygen is able to modulate NO produc-
tion in several organs and diﬀerent experimental conditions
by selectively inducing eNOS while inhibiting iNOS produc-
tion [13–15].
Although it can be expected that the prevention during
cold preservation of mitochondrial damage, glycogen deple-
tion, and oxidative injury, together with the increased endo-
thelial NO generation, can favour a rapid recovery of liver
graft viability after reperfusion, whether the use of HHMP
can eﬀectively improve the post-transplant outcome com-
paredtothecurrentstaticstorageremainsundeterminedand
needs to be assessed in experimental liver transplantation,
which was not technically feasible in the present study.
Besides that, several other aspects have to be tested in
order to optimize the use of the HHMP, including the
type of preservation solution, the rate and modalities of
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organ perfusion, and the degree of hyperbarism. In the pre-
sent study, we decided to minimize the number of the expe-
rimental variables in order to selectively assess the eﬀect of
hyperbarismcombinedornotwiththecontinuousperfusion
of the liver. With this objective in mind, we have utilized a
preservation solution currently employed in the static cold
storage as well as an intermediate rate of perfusion and a
medium level of hyperbarism among those employed in the
studies previously published [4, 7, 9, 15, 22, 34]. Of course,
it means that the use of preservation solutions speciﬁcally
designed for machine perfusion systems or diﬀerent perfu-
sion dynamics would likely produce some additional beneﬁt.
A potential pitfall associated with the continuous perfu-
sion of the graft is represented by the sinusoidal endothelial
cell (SEC) damage, which likely ensues, beside the well-
established detrimental eﬀects of hypothermia, from a
shear-stress phenomenon [9, 35], thus counterbalancing the
potential beneﬁts on cell metabolism. Several attempts to
improve SEC viability are under investigation, including8 The Scientiﬁc World Journal
modiﬁcations in the composition of the preservation solu-
tions and in the modalities of organ perfusion [7, 9, 34, 36].
In our experiments, while continuous perfusion with Celsior
solution at 1mL/min/g liver with hyperbaric oxygen did not
appear to be fully protective, we found that lowering the
rate of perfusion ﬂow to 0.5–0.2mL/min/grams of liver was
associated with a better preservation of the sinusoidal lining
(data not shown).
In conclusion, preservation by means of the present in-
novative HHMP, which combines the oxygenation of the
preservationsolutionwithhyperbaricoxygentothecontinu-
ous graft perfusion, reduced liver injury possibly by pre-
venting the mitochondrial damage, glycogen depletion and
oxidative damage which develop after the currently used
staticstorage.Interestingly,onlytheuseofhyperbaricoxygen
was associated to a blunted oxidative stress and an increased
eNOS gene expression. These results represent the rationale
background to test the HHMP in experimental liver trans-
plantation models.
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